Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation

Alemtuzumab is a monoclonal antibody targeting CD52, used as induction therapy after lung transplantation (LTx). Its engagement produces a long-lasting immunodepletion; however, the mechanisms driving cell reconstitution are poorly defined. We hypothesized that miRNAs are involved in this process. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Benazzo, A., Bozzini, S., Auner, S., Berezhinskiy, H. Oya, Watzenboeck, M. L., Schwarz, S., Schweiger, T., Klepetko, W., Wekerle, T., Hoetzenecker, K., Meloni, F., Jaksch, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056512/
https://www.ncbi.nlm.nih.gov/pubmed/35490174
http://dx.doi.org/10.1038/s41598-022-10866-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056512/
https://www.ncbi.nlm.nih.gov/pubmed/35490174
http://dx.doi.org/10.1038/s41598-022-10866-w

Ejemplares similares